Non Invasive Cancer Test (NICT): a Proof of Principle Study. (NICT-NIPT-CA)
Sponsor: Maastricht University Medical Center
A observational or N/A phase clinical study on Neoplasmata, this trial is actively recruiting participants. The trial is conducted by Maastricht University Medical Center and has accumulated 17 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
17 versions recorded-
Nov 2025 — Present [monthly]
Recruiting
Status: Unknown → Recruiting
-
Apr 2025 — Nov 2025 [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Apr 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Apr 2024 — Jul 2024 [monthly]
Recruiting
▶ Show 12 earlier versions
-
Apr 2023 — Apr 2024 [monthly]
Recruiting
-
Dec 2021 — Apr 2023 [monthly]
Recruiting
-
Oct 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Mar 2020 — Nov 2020 [monthly]
Recruiting
-
Apr 2019 — Mar 2020 [monthly]
Recruiting
-
Jun 2018 — Apr 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Feb 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Maastricht University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .